title: Factors affecting survival and tumor recurrence in patients transplanted for hepatocellular carcinoma and coexistent hepatitis C virus.
abstract: A better understanding of tumor factors influencing patient and graft survival and recurrence of hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) cirrhosis may be useful to maximize the benefits of liver transplantation (OLT). Sixty-three adults underwent OLT for end-stage liver disease secondary to HCV with concomitant HCC. The outcome measures were patient and graft survival, as well as recurrence-free survival, computed using a stepwise Cox proportional hazards regression analysis. Kaplan-Meier 1-, 3-, and 5-year patient survival rates were 82%, 80%, and 69%, respectively, they were better for incidentally discovered HCC compared with preoperatively diagnosed HCC (P = .04). The overall recurrence-free survival rates were 81%, 76%, and 61% at 1, 3, and 5 years, respectively. Univariate analysis showed that nonincidental HCC (P = .04), pTNM stage (P = .012) and vascular invasion (P = .003) correlated with recipient mortality. Vascular invasion (odds ratio [OR] = 2.12; P = .001) and pTNM (OR = 1.50; P = .008) were independent predictors of overall survival. A combination of tumor vascular invasion with advanced pTNM was associated with a dismal prognosis (log-rank = 21.89; P = .0001). Tumor grading (OR = 1.2; P = .04), pTNM (OR = 3.7; P = .001) and vascular invasion (OR = 1.6; P = .002) were independent predictors of recurrence. In conclusion, advanced pTNM and the presence of vascular invasion are strong predictors of poor survival and tumor recurrence.
authors.affiliation: Liver Transplantation Unit, Hospital Reina Sofía, Cordoba, Spain. javibriceno@hotmail.com
authors.forename: J
authors.initials: J
authors.lastname: Briceño
authors.forename: J
authors.initials: J
authors.lastname: Ruiz
authors.forename: R
authors.initials: R
authors.lastname: Ciria
authors.forename: A
authors.initials: A
authors.lastname: Naranjo
authors.forename: J
authors.initials: J
authors.lastname: Sánchez-Hidalgo
authors.forename: A
authors.initials: A
authors.lastname: Luque
authors.forename: S
authors.initials: S
authors.lastname: Rufián
authors.forename: M
authors.initials: M
authors.lastname: de la Mata
authors.forename: P
authors.initials: P
authors.lastname: López-Cillero
mesh_terms: D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000473:pathology / Q000601:surgery*; D015331:Cohort Studies; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000150:complications / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications / Q000401:mortality / Q000601:surgery*; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D012008:Recurrence; D012044:Regression Analysis; D012189:Retrospective Studies; D016019:Survival Analysis; D017741:Survivors; D013997:Time Factors